Showing results (1-10 of 170) with videos related to
Sort By:
Pageof 17
Current Opinion in Lipidology|August 1, 2017
Macrophage complexity in human atherosclerosis: opportunities for treatment?Erik A L Biessen, Kristiaan WoutersArteriosclerosis, Thrombosis, and Vascular Biology|October 14, 2021
N-Acetyl Galactosamine Targeting: Paving the Way for Clinical Application of Nucleotide Medicines in Cardiovascular DiseasesErik A L Biessen, Theo J C Van BerkelCellular and Molecular Life Sciences : CMLS|February 23, 2013
Inflammation and immune system interactions in atherosclerosisBart Legein, Lieve Temmerman, Erik A L Biessen, et al.Current Cardiology Reviews|November 26, 2009
Mast cells: pivotal players in cardiovascular diseasesIlze Bot, Theo J C van Berkel, Erik A L BiessenCardiovascular Drug Reviews|July 7, 2007
Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disordersHaixiang Yu, Theo J C van Berkel, Erik A L BiessenFuture Cardiology|May 20, 2009
Chemokines as therapeutic targets for atherosclerotic plaque destabilization and ruptureIsabelle T M N Daissormont, Adriaan O Kraaijeveld, Erik A L BiessenEuropean Journal of Pharmacology|October 10, 2017
Heterogeneity of atherosclerotic plaque macrophage origin, phenotype and functions: Implications for treatmentJan Nagenborg, Pieter Goossens, Erik A L Biessen, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 3, 2007
Assessment of unstable atherosclerosis in miceChristopher L Jackson, Martin R Bennett, Erik A L Biessen, et al.Cardiovascular Research|September 22, 2021
Two-faced Janus: the dual role of macrophages in atherosclerotic calcificationOlivia J Waring, Nikolaos T Skenteris, Erik A L Biessen, et al.Journal of Visualized Experiments : Jove|March 27, 2018
Characterization of Immune Cells in Human Adipose Tissue by Using Flow CytometrySuzan Wetzels, Mitchell Bijnen, Erwin Wijnands, et al.Pageof 17